Top compounds associated with response to RP11-322N21.2


Feature Type Standardized
Nominal ANOVA
mRNA lovastatin CTRPv2 pan-cancer AAC -0.071 0.05
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.06 0.05
mRNA GW843682X CTRPv2 pan-cancer AAC -0.066 0.05
mRNA paclitaxel UHNBreast pan-cancer AAC -0.57 0.05
mRNA SN-38 CTRPv2 pan-cancer AAC -0.067 0.06
mRNA Teniposide CTRPv2 pan-cancer AAC -0.071 0.06
mRNA VX-680 CTRPv2 pan-cancer AAC -0.18 0.06
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.058 0.07
mRNA BRD-K41597374 CTRPv2 pan-cancer AAC -0.063 0.07
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.05 0.07
Download CSV